Orexigen Therapeutics recalls
FDA enforcement reports naming Orexigen Therapeutics, Inc. as the recalling firm.
- Recall reports
- 2
- Class I (serious)
- 0
- Most recent report
- Nov 14, 2018
- Nov 14, 2018Contrave (naltrexone HCl and bupropion HCl)Drug · Orexigen Therapeutics, Inc.Container packaging defect.Class III
- Aug 22, 2018Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-c…Drug · Orexigen Therapeutics, Inc.Defective Container: Customer complaints of punctures in the bottle.Class III